Previous Page  28 / 108 Next Page
Information
Show Menu
Previous Page 28 / 108 Next Page
Page Background

21

groups in most cases suggests that the OIC group fares less well than countries of the non-OIC

group.

The only exception to this pattern is with regards the low-income group in the 1996-2000

period for which the life expectancy among the OIC group (53.9 years) was marginally higher than that

of the non-OIC group (53.4). However, even though the OIC group was ahead of the non-OIC group in

the period 1996-2000, by the end of the 20-year period the non-OIC group (63.7) had not only

overtaken the OIC group (60.9) but had also registered a respectable lead.

A similar trend pattern is seen with regard to the analysis of maternal mortality ratio (MMR) i

n Figure 11.

The low-income non-OIC group had a higher baseline MMR (765) figure compared to the

corresponding OIC group (744) in 1996-2000. Over the next 20 years its MMR value improved (to 448)

to reach a higher level than in the OIC group (457). The MMR statistics also support the earlier

assertion that the OIC group irrespective of their income has historically had worse health outcomes

than the non-OIC group. In addition to the life expectancy and the MMR analysis,

Figure 11

also

presents an analysis of the under 5 mortality which shows a broadly similar pattern.

The remaining indicators i

n Figure 11 d

isplay a different trend pattern. The indicator onmortality from

cardiovascular disease (CVD), cancer, diabetes or chronic respiratory disease (CRD) is the percent of

30-year-old-people who would die before their 70th birthday from any of CVD, cancer, diabetes, or

CVD, assuming that s/he would experience current mortality rates at every age and s/he would not

die from any other cause of death (e.g., injuries or HIV/AIDS). The weighted averages plotted in the

graph suggest a moderate, yet consistent, improvement over the 20-year period for all income-OIC

groups. However, the “income effect”, where high-income countries report better health outcomes

than the low-income counterparts, is perhaps less pronounced in this particular graph. This is

primarily because the low-income group has done better than the lower-middle income group for non-

OIC countries.

Incidence of tuberculosis in

Figure 11 i

s the estimated number of new and relapse tuberculosis (TB)

cases arising in a given year, expressed as the rate per 100,000 population. Trends within each of the

six income-IOC groups captured in the relevant graph suggest that

incidence of TB had indeed fallen

over the years

. For example, in the low income OIC group the incidence of TB had dropped from 197

in 1006-2000 to 171 in 2011-2015.

Similar trends are visible across all six groups with non-OIC

groups reporting a much sharper drop in the incidence of TB than the OIC group

. For example,

over the 20-year period the incidence of TB in the OIC countries within the low-income group had

dropped by a mere 26 cases per 100,000 population (197 - 171). Concurrently, the incidence had

dropped by 134 cases (386 - 252) in the non-IOC group in the same income group. Middle-income non-

OIC countries have low levels of incidence compared to their low-income counterparts. On the other

hand, the income effect is not as clear for the OIC countries; low income OIC countries do better than

lower-middle-income OIC countries. Clearly this result reflects the fact that some OIC countries such

as Bangladesh (3.7%of global total TB cases), Indonesia (10.3%of the total), Nigeria (5.9%of the total)

and Pakistan (5.2% of the total) are affected by large caseloads of TB despite being in the lower-middle

income category (WHO, 2015). In fact, all of these OIC countries are in the 22 TB high burden country

(HBC) list used by the WHO (

ibid

).

The last graph i

n Figure 11

captures the incidence of HIV, which is the number of new HIV infections

among uninfected populations aged 15-49 expressed as a per cent of the uninfected population in the

year before. In non-OIC countries, the incidence of HIV is lowest in middle income countries whereas

in OIC countries, the incidence of HIV steadily decreases with income level.

The difference in

incidence of HIV in high income countries is very stark with OIC countries achieving a

considerably lower level of exposure to HIV. In low and lower middle-income countries,

however, OIC countries tend to do less well than non-OIC countries

.

The above analysis of health outcomes hints that the need for and demand for health care services is

higher in the OIC countries at all levels of wealth. This finding provides the background for a detailed